The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis
- Resource Type
- Journal
- Source
CLINICAL CANCER RESEARCH ; MAR 15 2006, 12 6, p1839-p1849, 11p.- Subject
- Language
- English
- ISSN
- 10780432